Elisa Agostinetto· @ElisaAgostinett · X·· 1 day agoScore70
Body · original
At #ESMO26 rapid oral session on advanced #breastcancer
@KalinskyKevin presents results from postMONARCH
Abema + fulvestrant showed numeric, non significant ⬆️ OS in aBC after PD to CDK4-6i
Modest PFS improvement
@OncoAlert
125 views · 5 likes · 4 reposts · 1 reply
Conference abstracts
1ROmatched by Rapid oral 1: Breast cancer, advanced stage
Overall survival from the phase 3 postMONARCH trial of abemaciclib + fulvestrant vs placebo + fulvestrant for HR+, HER2- advanced breast cancer following progression on a prior CDK4/6 inhibitor + endocrine therapy
https://esmocongress.esmo.orgReplies in this thread
- Elisa Agostinetto@ElisaAgostinett
Simultaneous publication in @Annals_Oncology ‼️ https://www.annalsofoncology.org/article/S0923-7534%2826%2908075-0/fulltext @OncoAlert @myESMO
Source: Elisa Agostinetto · x.com